00670-0674-30

Loratadine Tablets

Loratadine Tablets ASAP can help source this line with documentation review, alternate part checks, condition requirements, and account manager follow-up for urgent or planned procurement.

Novartis Pharmaceuticals Corporation

Manufacturer

USA

Origin

N/A

Spec

N/A

Unit weight

Detailed description

Technical sourcing notes

N/A

Lead time

N/A

Cross references

Unrestricted

Export control

6505 Drugs and Biologicals

FSC

Why ASAP

Operations-grade aviation sourcing.

AS9120B

Quality-managed distribution

15 min

Average RFQ response, 24/7

Full trace

Documentation & certs on request

Submit RFQ

Request a quote for 00670-0674-30

Send this part to ASAP with quantity, need-by timing, and buyer contact details. An account manager will review availability, alternates, certificates, and delivery options.

Part-specific RFQ

Submit RFQ for 00670-0674-30

Send this part to ASAP with quantity, need-by timing, and buyer contact details. A dedicated account manager reviews availability, alternates, certificates, and delivery options.

Loratadine Tablets00670-0674-30

NSN6505-01-377-1461

Manufacturer: Novartis Pharmaceuticals Corporation
CAGE: 04520

NSN Information for Part Number 00670-0674-30 with NSN 6505-01-377-1461, 6505013771461

NSN	FSC	NIIN	CLS	Hazmat	DEMIL	Cancelled NSN
6505013771461 Item Description: Loratadine Tablets	6505	013771461	M	P
	CIIC	HCC	ESD	PMIC	Criticality	ENAC
	U			A
Part Number	ISC	RNVC	RNCC	HCC	MSDS	SADC
00670-0674-30	2	2	3

Characteristics Data of NSN 6505-01-377-1461, 6505013771461

MRC	Criteria	Characteristic
MRC	Decoded Requirement	Clear Text Reply
AKJA	Active Medicament Medicinal Strength	10.000 MILLIGRAMS LORATADINE ACTIVE INGREDIENT
CXCY	Part Name Assigned By Controlling Agency	LORATADINE TABLETS 10MG 30S PG
CBBL	Features Provided	UNIT DOSE
CRLK	Primary Container Content Quantity	10.000 TABLETS
THPE	Therapeutic Equivalent	SCHERING
CSCW	Total Primary Container Quantity	3
CQCT	Primary Container Type	CARD